Enanta Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $414.2M
Liabilities Breakdown FY2018
Total Liabilities: $20.5M
Asset Breakdown
Total Assets: $414.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $63.9M | 15.4% |
| Accounts Receivable | $67.2M | 16.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.4M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $274.7M | 66.3% |
Liabilities Breakdown
Total Liabilities: $20.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 23.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.8M | 76.9% |